For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Huyabio International, LLC

USPTO Granted Patents = 11

EPO Patents = 2

Trademarks = 1

Forward Citations = 4

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Mireille Gillings (7 out of 11 patents)

Suzanne J Romano (6 out of 7 patents)

Gary Elliott (6 out of 29 patents)

4. Robert Goodenow (5 out of 8 patents)

5. Reid P Bissonnette (2 out of 5 patents)

6. Alain Rolland (2 out of 7 patents)

7. Farbod Shojaei (2 out of 5 patents)

8. Jay Mason (2 out of 2 patents)

9. Waldemar Radziszewski (2 out of 2 patents)

10. Jill M Ricono (2 out of 2 patents)

11. Hayley Reece (1 out of 6 patents)

12. Joseph Edward Gordon Benson (1 out of 2 patents)

13. Sarah Collins (1 out of 2 patents)

14. Curtis Tyree (1 out of 2 patents)

15. Qidong You (1 out of 12 patents)

11 patents: Sort by Forward Citations

1. 12465587 - Sulcardine administration for treatment of acute atrial fibrillation (2025-11-11),

2. 12390469 - SHP2 inhibitor monotherapy and uses thereof (2025-08-19),

3. 12357611 - Sulcardine administration for treatment of acute atrial fibrillation (2025-07-15),

4. 12122833 - Combination therapies of HDAC inhibitors and PD-1 inhibitors (2024-10-22),

5. 12097203 - Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors (2024-09-24),

6. 12054478 - Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction (2024-08-06),

7. 11883380 - Sulcardine administration for treatment of acute atrial fibrillation (2024-01-30),

8. 11813245 - Sulcardine administration for treatment of acute atrial fibrillation (2023-11-14),

9. 11535670 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors (2022-12-27),

10. 11426382 - Sulcardine salts (2022-08-30),

11. 11364223 - Sulcardine administration for treatment of acute atrial fibrillation (2022-06-21),

Huyabio International, LLC is a leading biopharmaceutical company dedicated to developing and commercializing innovative medicines to address unmet medical needs. With a focus on oncology and rare diseases, Huyabio strives to improve patients' lives worldwide through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#466 in San Diego, CA

#6,343 in California

#26,744 in US

#50,230 in the World

San Diego, CA, United States of America

Huyabio International, LLC

Forward Citations = 4

19 inventors:

Mireille Gillings (7 out of 11 patents)

Suzanne J Romano (6 out of 7 patents)

Gary Elliott (6 out of 29 patents)

4. Robert Goodenow (5 out of 8 patents)

5. Reid P Bissonnette (2 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…